Notes

Slide Show

Outline

1	CLSC412 HEMOSTASIS
2	Unit Objectives - 1
3	Unit Objectives - 2
4	Unit Objectives - 3
5	Unit Objectives - 4
6	Thrombosis Testing
7	Definitions
8	Thrombosis
9	Venous vs Arterial Thrombosis
10	Acquired Risk Factors - 1
11	Acquired Risk Factors - 2
12	Diseases & Risk Factors - 1
13	Diseases & Risk Factors - 2
14	Lab Analysis – Acquired Risk Factors - 1
15	Lab Analysis – Acquired Risk Factors - 2
16	Congenital Risk Factors
17	Lab Tests & Congenital Risk Factors
18	Thrombosis Risk Testing Panels - 1
19	Thrombosis Risk Testing Panels - 2
20	Thrombosis Risk Testing Panels - 3
21	Thrombosis Risk Testing
22	CVD & CVA - 1
23	Markers of Arterial Thrombosis Risk
24	High-Sensitivity C-Reactive Protein
25	Plasma Homocysteine - 1
26	Plasma Homocysteine - 2
27	Fibrinogen (Factor I) - 1
28	Fibrinogen (Factor I) - 2
29	Lipoprotein (a)
30	Aspirin Therapy - 1
31	Aspirin Therapy Monitoring -1
32	Aspirin Therapy Monitoring - 2
33	Anti-Phospholipid Antibodies (APL) - 1
34	Anti-Phospholipid Antibodies (APL) - 2
35	Clinical Features of APL
36	Clinical Features of Autoimmune APL
37	Detecting & Confirming APL
38	Anti-Cardiolipin Antibodies (ACL)
39	Other APL Antibodies
40	Antithrombin
41	Antithrombin & Heparin
42	Antithrombin Deficiencies
43	Antithrombin & Heparin Resistance
44	Protein C & Protein S
45	Characteristics of Protein C & Protein S
46	Activated Protein C Resistance
47	Assay for Activated Protein C Resistance
48	Prothrombin 20210A
49	D.I.C. - 1
50	D.I.C. - 2
51	D.I.C. - 3
52	D.I.C. - 4
53	D.I.C. - 5
54	Pathophysiology of D.I.C.
55	Plasmin and D.I.C.
56	Coagulation Control Proteins in D.I.C.
57	Lab Diagnosis in D.I.C. - 1
58	Lab Diagnosis in D.I.C. - 1
59	Treatment of D.I.C.
60	Monitors for Localized Thrombosis - 1
61	Monitors for Localized Thrombosis - 2
62	Heparin-Induced Thrombocytosis with Thrombosis (HIT)
63	Clinical Features of HIT
64	Platelet Count in HIT
65	Lab Testing in HIT
66	Therapy for HIT
67	Thrombosis Risk Testing
68	Role of Protein C